All Type of News
Will counterattack of ‘injection’ in diabetes treatment make any chance in recognition?
Although the largest treatment in diabetes patients to control blood sugar is known to be ‘injection,’ its usage is relatively small in Korea compared to other foreign countries.
This is because of the fact that pati...
The leading DPP-4 inhibitor market worth of KRW 260 billion has been fueled again
The DPP-4 inhibitor-type diabetes treatment market has been fueled again.
Although 6 products have been competing in the market, Handok, which has shown its capacity in the diabetes market, also, entered the market a...
Listed pharmaceutical companies states “Reduction of sales management expenses was led to profitability improvement”
It is analyzed that listed pharmaceutical companies’ expense control on sales management has been lead to profitability.
According to the YakupDotCom’s analysis result of KOSPI and KOSDAQ listed pharmaceutical compan...
What is the reason why ‘The Sharp,’ a subsidiary company of Daewoong Pharmaceutical, does not have any conflict with the distribution association?
In regards to indirect expansion of some pharmaceutical companies to the pharmaceutical wholesale industry through operation of pharmaceutical e-commerce stores, the distribution filed has claimed strong opposition.
...
Emergence of the ‘first-titled’ domestic vaccines attracted the depressed domestic market
2 vaccines, titled as the ‘first’ in the domestic market, appeared.
One of them is GSK’s ‘Fluarix Tetra,’ a tetravalent flu vaccine called as the next-generation vaccine. A number of tetravalent vaccines have been la...
Tenelia targets the top Januvia by effectiveness comparison
Movements of ‘Tenelia(generic name: teneligliptin),’ a DPP-4 inhibitor launched for the 7th time in the domestic market, have been aggressive. Handok has stressed its goal to name the drug in the ‘Top 3’ by showing it...
12 pharmaceutical companies making over KRW 10 billion annual investment occupied 75% of the entire investment
The centerpiece of the pharmaceutical industry is new drug development, and power of the new drug development comes from research and development(R&D). A new drug not only play a savior role for pharmaceutical compani...
The first half’s sales performance of listed pharmaceutical company was ‘Good’
Despite various policy restrictions and the MERS crisis, it is analyzed that listed pharmaceutical companies made decent sales and profits in the first half of the year.
According to the YakupDotCom’s analysis result...
Ahngook Pharm enters the Cialis market with the ‘OD!FS Technology’ for the first time in the worldWhile a generic war has been anticipated due to the patent expiration of Cialis(tadalafil), a impotency drug, on the coming September, Ahngook Pharm will enter the impotency tre...
|
Will the second SGLT-2 insurance benefit decision form competition against DPP-4?
For the second time in the domestic market, a SGLT-2inhibitor is going to receive the health insurance from the 1st. The benefited drug is ‘Suglat(generic name: ipragliflozin). Its insured drug price will be KRW 705 p...
